| タイトル | Inhibition of 14-3-3/Tau by Hybrid Small-Molecule Peptides Operating via Two Different Binding Modes. |
|---|
| ジャーナル・号・ページ | ACS Chem Neurosci, Vol. 9, Page 2639-2654, Year 2018 |
|---|
| 掲載日 | 2017年12月18日 (構造データの登録日) |
|---|
著者 | Andrei, S.A. / Meijer, F.A. / Neves, J.F. / Brunsveld, L. / Landrieu, I. / Ottmann, C. / Milroy, L.G. |
|---|
リンク | ACS Chem Neurosci / PubMed:29722962 |
|---|
| 手法 | X線回折 |
|---|
| 解像度 | 1.25 - 2 Å |
|---|
| 構造データ | PDB-6fau: Crystal structure of C-terminal modified Tau peptide-hybrid 4.2e-I with 14-3-3sigma 手法: X-RAY DIFFRACTION / 解像度: 1.25 Å PDB-6fav: Crystal structure of C-terminal modified Tau peptide-hybrid 4.2f-I with 14-3-3sigma 手法: X-RAY DIFFRACTION / 解像度: 1.4 Å PDB-6faw: Crystal structure of C-terminal modified Tau peptide-hybrid 4.2c-I with 14-3-3sigma 手法: X-RAY DIFFRACTION / 解像度: 1.4 Å PDB-6fbw: Crystal structure of C-terminal modified Tau peptide-hybrid 4.2f-II with 14-3-3sigma 手法: X-RAY DIFFRACTION / 解像度: 1.45 Å PDB-6fby: Crystal structure of C-terminal modified Tau peptide-hybrid 4.2b with 14-3-3sigma 手法: X-RAY DIFFRACTION / 解像度: 1.5 Å PDB-6fi4: Crystal structure of C-terminal modified Tau peptide-hybrid 3.2e with 14-3-3sigma 手法: X-RAY DIFFRACTION / 解像度: 2 Å PDB-6fi5: Crystal structure of C-terminal modified Tau peptide-hybrid 3.2d with 14-3-3sigma 手法: X-RAY DIFFRACTION / 解像度: 1.7 Å |
|---|
| 化合物 | ChemComp-D3W: (2~{R})-2-[(~{R})-(2-methoxyphenyl)-phenyl-methyl]pyrrolidine
ChemComp-D3Q: (2~{R})-2-[(~{R})-(3-methoxyphenyl)-phenyl-methyl]pyrrolidine
ChemComp-D3K: (2~{R})-2-[(~{R})-[2-(2-methoxyethoxy)phenyl]-phenyl-methyl]pyrrolidine
ChemComp-D4K: (2~{R})-2-[(~{S})-(3-methoxyphenyl)-phenyl-methyl]pyrrolidine
ChemComp-D4H: (2~{R})-2-[(~{S})-(3-methylphenyl)-phenyl-methyl]pyrrolidine
|
|---|
| 由来 | homo sapiens (ヒト)
|
|---|
キーワード | STRUCTURAL PROTEIN / Tau 14-3-3 Alzheimer |
|---|